187 related articles for article (PubMed ID: 25285609)
1. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects.
Lei Y; Nosoudi N; Vyavahare N
J Control Release; 2014 Dec; 196():79-86. PubMed ID: 25285609
[TBL] [Abstract][Full Text] [Related]
2. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease.
Karamched SR; Nosoudi N; Moreland HE; Chowdhury A; Vyavahare NR
Sci Rep; 2019 Feb; 9(1):2629. PubMed ID: 30796300
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of reversal of aortic calcification by chelating agents.
Lei Y; Grover A; Sinha A; Vyavahare N
Calcif Tissue Int; 2013 Nov; 93(5):426-35. PubMed ID: 23963635
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles.
Nosoudi N; Chowdhury A; Siclari S; Karamched S; Parasaram V; Parrish J; Gerard P; Vyavahare N
Theranostics; 2016; 6(11):1975-1987. PubMed ID: 27698934
[TBL] [Abstract][Full Text] [Related]
5. EDTA chelation for calcific band keratopathy.
Arjamaa O
Am J Ophthalmol; 2005 Jan; 139(1):216; author reply 216. PubMed ID: 15652866
[No Abstract] [Full Text] [Related]
6. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
Ujueta F; Arenas IA; Escolar E; Diaz D; Boineau R; Mark DB; Golden P; Lindblad L; Kim H; Lee KL; Lamas GA
J Diabetes Complications; 2019 Jul; 33(7):490-494. PubMed ID: 31101487
[TBL] [Abstract][Full Text] [Related]
7. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
Nosoudi N; Nahar-Gohad P; Sinha A; Chowdhury A; Gerard P; Carsten CG; Gray BH; Vyavahare NR
Circ Res; 2015 Nov; 117(11):e80-9. PubMed ID: 26443597
[TBL] [Abstract][Full Text] [Related]
8. Pediatric fatality secondary to EDTA chelation.
Baxter AJ; Krenzelok EP
Clin Toxicol (Phila); 2008 Dec; 46(10):1083-4. PubMed ID: 18949650
[TBL] [Abstract][Full Text] [Related]
9. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
[TBL] [Abstract][Full Text] [Related]
10. Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005.
Brown MJ; Willis T; Omalu B; Leiker R
Pediatrics; 2006 Aug; 118(2):e534-6. PubMed ID: 16882789
[TBL] [Abstract][Full Text] [Related]
11. Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats.
Nosoudi N; Chowdhury A; Siclari S; Parasaram V; Karamched S; Vyavahare N
J Cardiovasc Transl Res; 2016 Dec; 9(5-6):445-455. PubMed ID: 27542007
[TBL] [Abstract][Full Text] [Related]
12. EDTA chelation for calcific band keratopathy: results and long-term follow-up.
Najjar DM; Cohen EJ; Rapuano CJ; Laibson PR
Am J Ophthalmol; 2004 Jun; 137(6):1056-64. PubMed ID: 15183790
[TBL] [Abstract][Full Text] [Related]
13. Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.
Atwood KC; Woeckner E; Baratz RS; Sampson WI
Medscape J Med; 2008 May; 10(5):115. PubMed ID: 18596934
[TBL] [Abstract][Full Text] [Related]
14. Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles.
Keuth J; Nitschke Y; Mulac D; Riehemann K; Rutsch F; Langer K
Eur J Pharm Biopharm; 2020 May; 150():108-119. PubMed ID: 32151731
[TBL] [Abstract][Full Text] [Related]
15. Chelation therapy in cardiovascular disease: an update.
Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
[TBL] [Abstract][Full Text] [Related]
16. Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles.
Feldmann A; Nitschke Y; Linß F; Mulac D; Stücker S; Bertrand J; Buers I; Langer K; Rutsch F
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003660
[TBL] [Abstract][Full Text] [Related]
17. By the way, doctor. I get mail extolling the virtues of chelation therapy. The claim is that it removes calcium and other metals from the walls of arteries. The key element appears to be EDTA. Since vinegar is also primarily acetic acid, I'm curious whether it could have the same effect.
Komaroff AL
Harv Health Lett; 2004 Mar; 29(5):8. PubMed ID: 15044137
[No Abstract] [Full Text] [Related]
18. Chelation treatment of atherosclerosis.
Magee R
Med J Aust; 1985 Apr; 142(9):514-5. PubMed ID: 3921813
[TBL] [Abstract][Full Text] [Related]
19. Chelation therapy in the treatment of cardiovascular diseases.
Ibad A; Khalid R; Thompson PD
J Clin Lipidol; 2016; 10(1):58-62. PubMed ID: 26892121
[TBL] [Abstract][Full Text] [Related]
20. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
